The global aquaculture vaccines market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). High aquaculture production, high prevalence of infectious diseases in the aquaculture sector, and growing demand for aquatic animal-derived food products are the factors expected to drive the market. Effective and safe vaccination programs are key tools for ensuring sustainable development of the aquaculture sector, which helps in meeting the growing protein demand globally.
Vaccination plays an important role in large-scale commercial fish farming and has been a key reason for the success of salmon cultivation. In addition to salmon and trout, commercial vaccines are available for channel catfish, European seabass and seabream, Japanese amberjack and yellowtail, tilapia and Atlantic cod. In general, empirically developed vaccines based on inactivated bacterial pathogens have proven to be very efficacious in fish. Furthermore, the global aquaculture vaccines market analysis includes some of the key market players such as Johnson & Johnson, Novartis International AG, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, and Antares Pharma, among others.
Market Coverage
Competitive Landscape: Johnson & Johnson, Novartis International AG, F. Hoffmann-La Roche AG, Pfizer Inc., Bayer AG, and Antares Pharma, among others.
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Aquaculture Vaccines Market by Segment
By Type
• Live Vaccines
• Inactivated Vaccines
• Other Vaccines
By Route of Administration
• Injection Vaccines
• Immersions Vaccines
• Oral Vaccines
By Application
• Viral Infection
• Bacterial Infection
• Others
Global Aquaculture Vaccines Market by Region
North America
Europe
Asia-Pacific
Rest of the World